CIMERLI

What is CIMERLI?

CIMERLI (ranibizumab) is a biosimilar prescription drug for treatment of Age related macular degeneration, Retinal Vein Occlusion, Macular edema due to diabetes mellitus, Diabetic Retinopathy and Myopic choroidal neovascularization. CIMERLI is a vascular endothelial growth factor inhibitor. It is available in the form of intravitreal injection.

See full Prescribing Information for important safety information and clinical studies.

How much does CIMERLI cost?

Cash price for 30-day supply is $900-1900.

Is there any coupon or saving program available?

Patient Assistance Prorgams and Coupons are found:

• Coherus Solutions: CIMERLI
• Copay Card Program

What are some alternatives to CIMERLI?

Other alternatives to CIMERLI may include:

• SUSVIMO
• BYOOVIZ
• LUCENTIS
• EYLEA HD
• EYLEA